Name the Biotechnology giant joins hands with the CytoSorbents Corporation on 13 September 2013 for exclusive commercialization of a novel therapy for the treatment of sepsis, in India.
Share
Lost your password? Please enter your email address. You will receive a link and will create a new password via email.
eAnswers Team
Biocon Ltd. India’s biotechnology giant has joined hands with the CytoSorbents Corporation on 13 September 2013 for exclusive commercialization of a novel therapy for the treatment of sepsis, in India.